Development of molecular probes for imaging sigma-2 receptors in vitro and in vivo

Central Nervous System Agents in Medicinal Chemistry

Volumn 9, Issue 3, 2009, Pages 230-245

  Mach, Robert Henry ^a,c   Wheeler, Kenneth Theodore ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAKE FOREST UNIVERSITY HEALTH SCIENCES   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell proliferation; Positron emission tomography; Sigma 2 receptors

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; LIGAND; SIGMA 2 OPIATE RECEPTOR; TRACER;

CHEMICAL ANALYSIS; HUMAN; IMAGING; IN VITRO STUDY; IN VIVO STUDY; ISOTOPE LABELING; MOLECULAR PROBE; NEOPLASM; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RECEPTOR BINDING; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SOLID TUMOR; TISSUE CULTURE; TUMOR CELL;

EID: 69249133746     PISSN: 18715249     EISSN: None     Source Type: Journal    
DOI: 10.2174/1871524910909030230     Document Type: Review

References (68)

1. Walker, J.M.; Bowen, W.D.; Walker, F.O.; Matsumoto, R.R.; De Costa, B.; Rice, K.C. Sigma receptors: biology and function. Pharmacol. Rev., 1990, 42, 355-402.
2. Hellewell, S.B.; Bruce, A.; Feinstein, G.; Orringer, J.; Williams, W.; Bowen, WD. Rat liver and kidney contain high densities of sigma-1 and sigma-2 receptors: characterization by ligand binding and photoaffinity labeling. Eur. J. Pharmacol. Mol. Pharmacol. Sec., 1994, 268, 9-18. (Pubitemid 2104693)
3. 3H]SKF-10,047 binding to sigma-1 receptors in the mouse forebrain. J. Neurosci. Res., 1996, 46, 734-743.
4. Maurice, T.; Junien, J.-.L.; Privat A. Dehydroepiandrosterone sulfate attenuates dizocilpine-induced learning impairment in mice via sigma-1-receptors. Behav. Brain Res., 1997, 83, 159-164.
5. Romieu, P.; Martin-Fardon, R.; Bowen, W.D.; Maurice, T. Sigma-1 receptor-related neuroactive steroids modulate cocaine-induced reward. J. Neurosci., 2003, 23, 3572-3576. (Pubitemid 36958464)
6. Hanner, M.; Moebius, F.F.; Flandorfer, A.; Knaus, H.-G.; Striessnig, J.; Kempner, E.; Glossmann, H. Purification, molecular cloning, and expression of the mammalian sigma-1 binding site. Proc. Natl. Acad. Sci. USA, 1996, 93, 8072-8077.
7. Seth, P.; Leibach, F.H.; Ganapathy, V. Cloning and structural analysis of the cDNA and the gene encoding the murine type 1 sigma receptor. Biochem. Biophys. Res. Commun., 1997, 24, 535-540.
8. Alonso, G.; Phan, V.-L.; Guillemain, I.; Saunier, M.; Legrand, A.; Anoal, M.; Maurice, T. Immunocytochemical localization of the sigma-1 receptor in the adult rat central nervous system. Neuroscience, 2000, 97, 155-170. (Pubitemid 30195885)
9. Bem, W.T.; Thomas, G.E.; Mamone, J.Y.; Homan, S.M.; Levy, B.K.; Johnson, F.E.; Coscia CJ. Overexpression of sigma receptors in nonneural human tumors. Cancer Res., 1991, 51, 6558-6562.
10. Vilner, B.J.; John, C.S.; Bowen, W.D. Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res., 1995, 55, 408-413.
11. Wang, B.; Rouzier, R.; Albarracin, C.T.; Sahin, A.; Wagner, P.; Yang, Y.; Smith, T.L.; Meric-Bernstam, F.; Marcelo Aldez, C.; Hortobagyi, G.N.; Pusztai, L. Expression of sigma-1 receptor in human breast cancer. Breast Cancer Res. Treat., 2004, 87, 205-214.
12. Mach, R.H.; Wheeler, K.T. Imaging the proliferative status of tumors with PET. J. Labelled Comp. Radiopharm., 2007, 50, 366-369.
13. nd Ed. Mendelsohn, J.; Howley, P.M.; Israel, M.A.; Liotta, L.A., (Ed.); W. B. Saunders Co: Philadelphia, 2001; pp. 423-466.
14. Collins, I.; Garrett, M.D. Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors. Curr. Opin. Pharmacol., 2005, 5, 366-373.
15. Strebhardt, K.; Ulrich, A. Targeting polo-like kinase 1 for cancer therapy. Nat. Rev. Cancer, 2006, 6, 321-330.
16. Wallen, C.A.; Higashikubo, R.; Dethlefsen, L.A. Murine mammary tumour cells in vitro. I. The development of a quiescent state. Cell Tissue Kinet., 1984, 17, 65-77. (Pubitemid 14199681)
17. Wallen, C.A.; Higashikubo, R.; Dethlefsen, L.A. Murine mammary tumour cells in vitro. II. Recruitment of quiescent cells. Cell Tissue Kinet., 1984, 17, 79-89. (Pubitemid 14199682)
18. Mach, R.H.; Smith, C.R.; Al-Nabulsi, I.; Whirrett, B.R.; Childers, S.R.; Wheeler, K.T. Sigma-2 receptors as potential biomarkers of proliferation in breast cancer. Cancer Res., 1997, 57, 156-161. (Pubitemid 27020346)
19. Al-Nabulsi, I.; Mach, R.H.; Sten, K.; Childers, S.R.; Wheeler, K.T. Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumor cells. Br. J. Cancer, 1999, 81, 925-933.
20. Wheeler, K.T.; Wang, L.M.; Wallen, C.A.; Childers, S.R.; Cline, J.M.; Keng, P.C.; Mach, R.H. Sigma-2 receptors as a biomarker of proliferation in solid tumours. Br. J. Cancer, 2000, 82, 1223-1232.
21. Bowen, W.D.; Bertha, C.M.; Vilner, B.J.; Rice, K.C. CB-64D and CB-184: ligands with high sigma-2 receptor affinity and subtype selectivity. Eur. J. Pharmacol., 1995, 278, 257-260.
22. Bertha, C.M.; Mattson, M.V.; Flippen-Anderson, J.L.; Rothman, R.B.; Xu, H.; Cha, X.-Y.; Becketts, K.; Rice, K.C. A marked change of receptor affinity of the 2-methyl-5-(3-hydroxyphenyl)morphans upon attachment of an (E)-8-benzylidene moiety: synthesis and evaluation of a new class of σ receptor ligands. J. Med. Chem., 1994, 37, 3163-3167.
23. Perregaard, J.; Moltzen, E.K.; Meier, E.; Sanchez, C. σ Ligands with subnanomolar affinity and preference for the sigma-2 binding site.1. 3-(ω-aminoalkyl)-1H-indoles. J. Med. Chem., 1995, 38, 1998-2008.
24. 2 binding site. 2. Spiro-joined benzofuran, isobenzofuran, and benzopyran piperidines. J. Med. Chem., 1995, 38, 2009-2017.
25. 2-site in rat and human brain. Neuropharmacology, 2002, 43, 95-100.
26. Ostenfeld, M.S.; Fehrenbacher, N.; Høyer-Hansen, M.; Thomsen, C.; Farkas, T.; Jäättelä, M. Effective tumor cell death by sigma-2 receptor ligand siramesine involves lysosomal leakage and oxidative stress. Cancer Res., 2005, 65, 8975-8983. (Pubitemid 41377389)
27. Vilner, B.J.; Bowen, W.D. Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells. J. Pharmacol. Exp. Ther., 2000, 292, 900-911.
28. 2 receptor-selective ligands with moderate affinity. Eur. J. Pharmacol., 1995, 279, R1-R3.
29. 2 receptors. Life Sci., 1995, 57, PL 57-62.
30. 3 receptor ligand in NG-108 cells, selectively labels sigma-2 binding sites in guinea pig hippocampus. J. Pharmacol. Exp. Ther., 1993, 267, 961-970.
31. 2 receptors. Life Sci., 1999, 64, PL131-137.
32. 2 anatagonist. Pharm. Biochem. Behav., 2000, 67, 659-662.
33. Nguyen, V.H.; Kassiou, M.; Johnston, G.A.; Christie, M.J. Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Eur. J. Pharmacol., 1996, 311, 233-240.
34. 1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer. Mol. Cancer Ther., 2006, 5, 1807-1816.
35. Mach, R.H.; Yang, B.; Wu, L.; Kuhner, R.J.; Whirrett, B.R.; West, T. Synthesis and sigma receptor binding affinities of 8-azabicyclo[3.2.1]octan-3 -yl and 9-azabicyclo[3.3.1]nonao-3 -yl phenylcarbamates. Med. Chem. Res., 2001, 10, 339-355.
36. Mach, R.H.; Vangveravong, S.; Huang, Y.; Yang, B.; Blair, J.B.; Wu, L. Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3 -yl phenylcarbamate analogs as sigma-2 receptor ligands. Med. Chem. Res., 2003, 11, 380-398.
37. 2 receptor ligands. Bioorg. Med. Chem., 2006, 14, 6988-16897
38. Zeng, C.; Vangveravong, S.; Xu, J.; Chang, K.C.; Hotchkiss, R.S.; Wheeler, K.T.; Shen, D.; Zhuang, Z.-P.; Kung, H.F.; Mach, R.H. Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. Cancer Res., 2007, 67, 6708-6716.
39. 2 receptor ligands. Bioorg. Med. Chem. Lett., 2004, 14, 195-202.
40. 3 receptor ligands. Bioorg. Med. Chem., 2005, 13, 77-87.
41. 3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative study. Brain Res., 1992, 581, 33-38.
42. 3H](+)-pentazocine binding sites in rat brain: autoradiographic visualization of the putative sigma-1 and sigma-2 receptor subtypes. Neuroscience, 1997, 76, 467-477.
43. Torrence-Campbell, C.; Bowen, W.D. Differential solubilization of rat sigma-1 and sigma-2 receptors: retention of sigma-2 sites in particulate fractions. Eur. J. Pharmacol., 1996, 304, 201-210.
44. Gebreselassie, D.; Bowen, W.D. Sigma-2 receptors are specifically localized to lipid rafts in rat liver membranes. Eur. J. Pharmacol., 2004, 493, 19-28.
45. 3H]N-[4-(3,4-dihydro-6,7-dimethoxy-isoquinolin-2(1H)-yl)butyl] -2-methoxy-5-methylbenzamide: a Novel sigma-2 receptor probe. Eur. J. Pharmacol., 2005, 525, 8-17.
46. Colabufo, N.A.; Abate, C.; Contino, M.; Inglese, C.; Ferorelli, S.; Berardi, F.; Perrone, R. Tritium radiolabeling of PB28, a potent sigma-2 receptor ligand: pharmacokinetic and pharmacodynamic characterization. Bioorg. Med. Chem. Lett., 2008, 18, 1484-1488.
47. 125I]N-[2-(4-iodophenyl) ethyl]-N-methyl-2-(1-piperidinyl)ethylamine: a high affinity ligand for imaging sigma receptor positive tumors. Nucl. Med. Biol., 1996, 23, 761-766.
48. 123I-labeled piperidine-based sigma receptor ligands as potential melanoma imaging agents: initial studies in mouse tumor models. Nucl. Med. Biol., 1997, 24, 587-593.
49. 125I]MBA) for imaging breast cancer. Nucl. Med. Biol., 1999, 26, 377-382.
50. Hou, C.; Tu, Z.; Mach, R.H.; Kung, H.K.; Kung, M.-P. Characterization of a novel radioiodinated sigma-2 receptor ligand as a cell proliferation marker. Nucl. Med. Biol., 2006, 33, 203-209.
51. 125I]IUDR. Nucl. Med. Biol., 2001, 28, 451-458.
52. Schwartz, J.L.; Tamura, Y.; Jordan, R.; Grierson, J.R.; Krohn, K.A. Monitoring tumor cell proliferation by targeting DNA synthetic processes with thymidine and thymidine analogs. J. Nucl. Med., 2003, 44, 2027-2032.
53. 2 receptor ligands: synthesis, in vitro characterization, and evaluation as PET imaging and chemosensitization agents. Bioorg. Med. Chem., 2009, 17(3), 1222-1231.
54. Tu, Z.; Dence, C.S.; Ponde, D.E.; Jones, L.; Wheeler, K.T.; Welch, M.J.; Mach, R.H. Carbon-11 labeled sigma-2 receptor ligands for imaging breast cancer. Nucl. Med. Biol., 2005, 32, 423-430.
55. Tu, Z.; Xu, J.; Jones, L.A.; Li, S.; Dumsdorf, C.; Vangveravong, S.; Chen, D.; Wheeler, K.T.; Welch, M.J.; Mach, R.H. Fluorine-18 labeled benzamide analogs for imaging the sigma-2 receptor status of solid tumors with positron emission tomography. J. Med. Chem., 2007, 50, 3194-3204.
56. 76Br-labeled sigma2-receptor ligands. J. Nucl. Med., 2006, 47, 1041-1048.
57. 99mTc-Labeled sigma-binding complex: synthesis, characterization, and specific binding to human ductal breast carcinoma (T47D) cells. Bioconjug. Chem., 1997, 8, 304-309.
58. 99mTc] Oxotechnetium (V) complexes of amine-amide-dithiol chelates with dialkylaminoalkyl substituents as potential diagnostic probes for malignant melanoma. J. Med. Chem., 2001, 44, 3132-3140.
59. 123I-MEL037, for malignant melanoma. J. Nucl. Med., 2007, 48, 1348-1356.
60. Eisenhut, M.; Hull, W.E.; Mohammed, A.; Mier, W.; Lay, D.; Just, W.; Gorgas, K.; Lehmann, W.D.; Haberkorn, U. Radioiodinated N-(2-diethylaminoethyl) benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization. J. Med. Chem., 2000, 43, 3913-3922.
61. Mach, R.H.; Wheeler, K.T.; Blair, S.; Yang, B.; Day, C.S.; Blair, J.B.; Choi, S.R.; Kung, K.F. Preparation of a technetium-99m SPECT agent for imaging the sigma-2 receptor status of solid tumors. J. Labelled Comp. Radiopharm., 2001, 44, 899-908.
62. Choi, S.-R.; Yang, B.; Plossl, K.; Chumpradit, S.; Wey, S.-P.; Acton, P.D.; Wheeler, K.T.; Mach, R.H.; Kung, H.F. Development of a Tc-99m labeled sigma-2 receptor-specific ligand as potential breast tumor imaging agent. Nucl. Med. Biol., 2001, 28, 657-666.
63. Crawford, K.W.; Coop, A.; Bowen, W.D. Sigma-2 receptors regulate changes in sphingolipid levels in breast tumor cells. Eur. J. Pharmacol., 2002, 443, 207-209.
64. Zeng, C.; Vangveravong, S.; Xu, J.; Chang, K.C.; Hotchkiss, R.S.; Wheeler, K.T.; Shen, D.; Zhuang, Z.-P.; Kung, H.F.; Mach, R.H. Subcellular localization of sigma-2 receptors in breast cancer cells using two-photon and confocal microscopy. Cancer Res., 2007, 67, 6708-6716.
65. Crawford, K.W.; Bowen, W.D. Sigma-2 receptor agonists activate a novel apoptotic pathway and potentiate antineoplastic drugs in breast tumor cell lines. Cancer Res., 2002, 62, 313-322.
66. Chwieralski, C.E.; Welte, T.; Buhling, F. Cathepsin-regulated apoptosis. Apoptosis, 2006, 11, 143-149.
67. Brown, D.A.; London, E. Functions of lipid rafts in biological membranes. Annu. Rev. Cell Dev. Biol., 1998, 14, 111-136.
68. Simons, K.; Toomre, D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol., 2000, 1, 31-39.